Assessment of Ki67 in Breast Cancer: Recommendations From the International Ki67 in Breast Cancer Working Group

Journal of the National Cancer Institute - United Kingdom
doi 10.1093/jnci/djr393
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Ki67 Measured After Neoadjuvant Chemotherapy for Primary Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Dimensional Analysis of CD44High CD24Low and Ki67 in Triple Negative Breast Cancer

Open Access Macedonian Journal of Medical Sciences
Medicine
2019English

Ki67 Proliferation in Core Biopsies Versus Surgical Samples - A Model for Neo-Adjuvant Breast Cancer Studies

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Critical Assessment of the Clinical TNM System in Breast Cancer. Report From the Yorkshire Breast Cancer Group.

BMJ
1980English

23. Inclusion of KI67 Significantly Improves Performance of the Predict Prognostication and Prediction Model for Early Breast Cancer

European Journal of Surgical Oncology
MedicineOncologySurgery
2014English

Ki67 Is a Promising Molecular Target in the Diagnosis of Cancer (Review)

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Associations and Indications of Ki67 Expression With Clinicopathological Parameters and Molecular Subtypes in Invasive Breast Cancer: A Population-Based Study

Oncology Letters
Cancer ResearchOncology
2015English

De-Escalated Therapy for HR+/HER2+ Breast Cancer Patients With Ki67 Response After 2 Weeks Letrozole: Results of the PerELISA Neoadjuvant Study

Annals of Oncology
MedicineOncologyHematology
2019English

Association of XPO1 Overexpression With NF-κB and Ki67 in Colorectal Cancer

Asian Pacific Journal of Cancer Prevention
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy